DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Hardman Johnston Global Advisors LLC

Hardman Johnston Global Advisors LLC trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 9.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 596,392 shares of the medical instruments supplier’s stock after selling 63,995 shares during the quarter. Hardman Johnston Global Advisors LLC owned approximately 0.29% of DENTSPLY SIRONA worth $16,138,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 753 shares in the last quarter. LRI Investments LLC grew its stake in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares in the last quarter. Rothschild Investment LLC acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $32,000. Van ECK Associates Corp purchased a new position in DENTSPLY SIRONA in the 3rd quarter worth approximately $42,000. Finally, Central Pacific Bank Trust Division acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $64,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Up 0.2 %

NASDAQ:XRAY opened at $23.39 on Wednesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $22.84 and a fifty-two week high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The company has a 50 day moving average price of $25.00 and a 200 day moving average price of $26.06.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Wednesday. Needham & Company LLC reduced their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Stifel Nicolaus lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Finally, Barrington Research reiterated an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $31.88.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.